These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11591356)

  • 1. Dosage considerations with perindopril for systemic hypertension.
    Sica DA
    Am J Cardiol; 2001 Oct; 88(7A):13i-18i. PubMed ID: 11591356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of perindopril in the treatment of systemic hypertension.
    Oparil S
    Am J Cardiol; 2001 Oct; 88(7A):3i-12i. PubMed ID: 11591355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perindopril: an updated review of its use in hypertension.
    Hurst M; Jarvis B
    Drugs; 2001; 61(6):867-96. PubMed ID: 11398915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive efficacy of perindopril 5-10 mg/day in primary health care: an open-label, prospective, observational study.
    Ionescu DD;
    Clin Drug Investig; 2009; 29(12):767-76. PubMed ID: 19888783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
    Brugts JJ; Ferrari R; Simoons ML
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of perindopril.
    Lees KR
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():7-8; discussion 9-11. PubMed ID: 2283658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perindopril. A review of its pharmacokinetics and clinical pharmacology.
    Macfadyen RJ; Lees KR; Reid JL
    Drugs; 1990; 39 Suppl 1():49-63. PubMed ID: 2407493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perindopril: in congestive heart failure.
    Simpson D; Noble S; Goa KL
    Drugs; 2002; 62(9):1367-77; discussion 1378-9. PubMed ID: 12076191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perindopril/indapamide 2/0.625 mg/day: a review of its place in the management of hypertension.
    Matheson AJ; Cheer SM; Goa KL
    Drugs; 2001; 61(8):1211-29. PubMed ID: 11465878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perindopril: a review of its use in patients with or at risk of developing coronary artery disease.
    Curran MP; McCormack PL; Simpson D
    Drugs; 2006; 66(2):235-55. PubMed ID: 16451098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Efficacy of Perindopril/Amlodipine in Reaching Blood Pressure Targets: Results of the CONTROL Study.
    Abdelhady A; Khader S; Sinnuqrut S; Albow A
    Clin Drug Investig; 2016 May; 36(5):357-66. PubMed ID: 26832739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure response to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Reid JL; MacFadyen RJ; Squire IB; Lees KR
    Am J Cardiol; 1993 Jun; 71(17):57E-60E. PubMed ID: 8392282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders.
    Todd PA; Fitton A
    Drugs; 1991 Jul; 42(1):90-114. PubMed ID: 1718688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group.
    Vítovec J; Spinar J
    Eur J Heart Fail; 2000 Sep; 2(3):299-304. PubMed ID: 10938492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perindopril.
    O'Loughlin DC; Chu VL; Singh D
    Heart Dis; 2000; 2(6):446-55. PubMed ID: 11728296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of anti-hypertensive effect after missed dose of perindopril.
    Tan KW; Leenen FH
    Br J Clin Pharmacol; 1999 Oct; 48(4):628-30. PubMed ID: 10583036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term angiotensin-converting enzyme inhibitor perindopril therapy improves cerebral perfusion reserve in patients with previous minor stroke.
    Hatazawa J; Shimosegawa E; Osaki Y; Ibaraki M; Oku N; Hasegawa S; Nagata K; Hirata Y; Miura Y
    Stroke; 2004 Sep; 35(9):2117-22. PubMed ID: 15256675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the angiotensin-converting enzyme inhibitor perindopril on 24-hour blood pressure in patients with lacunar infarction: comparison between dippers and non-dippers.
    Yamamoto Y; Oiwa K; Hayashi M; Ohara T; Muranishi M
    Hypertens Res; 2005 Jul; 28(7):571-8. PubMed ID: 16335885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.